---
source: federal-register
document_id: "2025-23691"
title: "Prospective Grant of an Exclusive Patent License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1, or TRAT1"
agencies: ["Health and Human Services Department", "National Institutes of Health"]
published: 2025-12-23
fetched: 2025-12-28
type: notice
url: https://www.federalregister.gov/documents/2025/12/23/2025-23691/prospective-grant-of-an-exclusive-patent-license-enhanced-tumor-reactivity-of-t-cells-lacking-sit1
---

## Abstract
The Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health, United States Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice to EnZeta Immunotherapies, Inc., a company located in Coral Gables, FL.

## Key Details
- **Type:** notice
- **Agencies:** Health and Human Services Department, National Institutes of Health
- **Published:** 2025-12-23
- **Source:** [federal-register](https://www.federalregister.gov/documents/2025/12/23/2025-23691/prospective-grant-of-an-exclusive-patent-license-enhanced-tumor-reactivity-of-t-cells-lacking-sit1)
